Loading company…
Shenzhen Sibionics develops medical devices and AI solutions for chronic conditions, screening, diagnosis, and treatment.
Established in 2015 and based in Shenzhen, China, Shenzhen Sibionics develops active implantable medical devices and medical AI. Its work includes retinal prostheses, continuous glucose monitoring, and diabetic retinopathy screening, alongside solutions for chronic condition management, diagnosis, and treatment. The company had more than 400 employees as of 2022 and offices in Beijing, Guangzhou, and Los Angeles. It planned to use Series C3 funding for continuous glucose monitoring research and promotion.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in